D.H.E. 45 Drug Patent Profile
✉ Email this page to a colleague
When do D.h.e. 45 patents expire, and what generic alternatives are available?
D.h.e. 45 is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for D.h.e. 45
A generic version of D.H.E. 45 was approved as dihydroergotamine mesylate by PADAGIS US on April 28th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for D.H.E. 45?
- What are the global sales for D.H.E. 45?
- What is Average Wholesale Price for D.H.E. 45?
Summary for D.H.E. 45
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Patent Applications: | 1,250 |
| What excipients (inactive ingredients) are in D.H.E. 45? | D.H.E. 45 excipients list |
| DailyMed Link: | D.H.E. 45 at DailyMed |
US Patents and Regulatory Information for D.H.E. 45
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | D.H.E. 45 | dihydroergotamine mesylate | INJECTABLE;INJECTION | 005929-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
